27692-35-9

Basic information

• Product Name: 4-(chloroethoxy)aniline
• Synonyms: 4-(chloroethoxy)aniline;4-(2-Chloroethoxy)aniline;Benzenamine,4-(2-chloroethoxy)-;4-(2-Chloroethoxy)Aniline(WX630054)
• CAS NO: 27692-35-9
• Molecular Formula: C₈H₁₀ClNO
• Molecular Weight: 171.6241
• EINECS: 248-609-2
• Mol File: 27692-35-9.mol
• Article Data: 11

Chemical Properties

• Boiling Point: 299.8°Cat760mmHg
• Flash Point: 135.1°C
• Appearance: /
• Density: 1.195g/cm³
• Vapor Pressure: 0.00117mmHg at 25°C
• Refractive Index: 1.563
• CAS DataBase Reference: 4-(chloroethoxy)aniline(CAS DataBase Reference)
• NIST Chemistry Reference: 4-(chloroethoxy)aniline(27692-35-9)
• EPA Substance Registry System: 4-(chloroethoxy)aniline(27692-35-9)

Safety Data

• Hazardous Substances Data: 27692-35-9(Hazardous Substances Data)

Usage

InChI:InChI=1/C8H10ClNO/c9-5-6-11-8-3-1-7(10)2-4-8/h1-4H,5-6,10H2

Upstream product

• 36616-28-1 2-(4-acetamidophenoxy)ethyl chloride 
• 103-90-2 4-acetaminophenol 
• 50375-15-0 2-[4-(acetylamino)phenoxy]ethanol 
• 3383-72-0 1-(2-chloroethoxy)-4-nitrobenzene 
• 100-02-7 4-nitro-phenol 

Downstream Products

• 38519-24-3 [4-(2-chloro-ethoxy)-phenyl]-(6-methoxy-benzothiazol-2-yl)-amine 
• 38519-25-4 [4-(2-chloro-ethoxy)-phenyl]-(6-chloro-5-methoxy-benzothiazol-2-yl)-amine 
• 23831-73-4 3-[4-(2-Chloro-ethoxy)-phenyl]-1,1-dimethyl-urea 
• 23831-76-7 1-[4-(2-Chloro-ethoxy)-phenyl]-3-methyl-urea 
• 23831-72-3 C₁₁H₁₅ClN₂O₃ 
• 401514-13-4 4-[2-(3-benzyl-3,8-diaza-bicyclo[3.2.1]oct-8-yl)-ethoxy]-phenylamine 
• 38519-97-0 (6-chloro-5-methoxy-benzothiazol-2-yl)-[4-(2-piperidin-1-yl-ethoxy)-phenyl]-amine 
• 62345-76-0 4-<2-(dimethylamino)ethoxy>aniline 
• 242477-99-2 2-amino-N-[4-(2-chloro-ethoxy)-phenyl]-4-methoxy-benzamide 
• 242478-08-6 2-amino-N-[4-(2-chloro-ethoxy)-phenyl]-3-methoxy-benzamide 
• 38519-26-5 [4-(2-chloro-ethoxy)-phenyl]-(5-methoxy-benzothiazol-2-yl)-amine 

Relevant articles and documents

Dithiocarbamate type compound used as BTK (Bruton Tyrosine Kinase) inhibitor

The invention aims at providing a dithiocarbamate type compound used as a BTK (Bruton Tyrosine Kinase) inhibitor and a pharmaceutical composition thereof, a preparation method and application. The compound provided by the invention has a structure shown as a general formula (I). The formula (I) is shown in the description.

DIARYLAMINE-CONTAINING COMPOUNDS AND COMPOSITIONS, AND THEIR USE AS MODULATORS OF C-KIT RECEPTORS

Described herein are compounds that include a diarylamine structural feature. Also described herein are methods for making such compounds, methods for using such compounds to modulate the activity of c-kit receptors, and pharmaceutical compositions and medicaments comprising such compounds. Also described herein are methods of using such compounds, pharmaceutical compositions and medicaments to treat and/or prevent and/or inhibit and/or ameliorate the pathology and/or symptomology diseases or conditions associated with the activity of c-kit receptors.

PHENYL-[4-(3-PHENYL-1H-PYRAZOL-4-YL)-PYRIMIDIN-2-Yl)-AMINE DERIVATIVES

The invention relates to phenyl-[4-(3-phenyl-1H-pyrazol-4-yl)-pyrimidin-2-yl)-amine derivatives and to processes for the preparation thereof, to pharmaceutical compositions comprising such derivatives and to the use of such derivatives - alone or in combination with one or more other pharmaceutically active compounds - for the preparation of pharmaceutical compositions for the treatment especially of a proliferative disease, such as a tumour.